Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
Nov 07, 2023
Read MoreZai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7, 2023
Oct 18, 2023
Read MoreZai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injection) in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in China
Sep 18, 2023
Read MoreZai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib for Treatment of Patients with NTRK-positive TKI-pretreated advanced solid tumors in China
Aug 30, 2023
Read MoreZai Lab Announces Second Quarter 2023 Financial Results and Corporate Updates
Aug 07, 2023
Read MoreZai Lab to Announce Second Quarter 2023 Financial Results and Corporate Updates on August 7, 2023
Jul 20, 2023
Read More